Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dumitru Chesov

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|September 19, 2019
Management of drug-resistant tuberculosisChristoph Lange, Keertan Dheda, Dumitru Chesov, et al.
Plos One|March 19, 2015
Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infectionDumitru Chesov, Christoph Lange, Franziska Daduna, et al.
Lancet (London, England)|March 9, 2020
Challenging the management of drug-resistant tuberculosis - Authors' replyChristoph Lange, Keertan Dheda, Dumitru Chesov, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2025
Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European settingValeriu Crudu, Dumitru Chesov, Alexandru Codreanu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2023
Long-term treatment outcomes in patients with multidrug-resistant tuberculosisChristina Maier, Dumitru Chesov, Dagmar Schaub, et al.
Emerging Infectious Diseases|March 2, 2025
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023Olha Konstantynovska, Tetiana Synenko, Alla Honcharenko, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
In replyMatthias Merker, Valeriu Crudu, Ecaterina Noroc, et al.
Respiration; International Review of Thoracic Diseases|May 31, 2021
Defining Outcomes of Tuberculosis (Treatment): From the Past to the FutureGunar Günther, Jan Heyckendorf, Jean Pierre Zellweger, et al.
The European Respiratory Journal|December 18, 2020
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden countryDumitru Chesov, Jan Heyckendorf, Sofia Alexandru, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of MoldovaDumitru Chesov, Maja Reimann, Tishya Mukherjee, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|September 19, 2019
Management of drug-resistant tuberculosisChristoph Lange, Keertan Dheda, Dumitru Chesov, et al.
Plos One|March 19, 2015
Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infectionDumitru Chesov, Christoph Lange, Franziska Daduna, et al.
Lancet (London, England)|March 9, 2020
Challenging the management of drug-resistant tuberculosis - Authors' replyChristoph Lange, Keertan Dheda, Dumitru Chesov, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2025
Diagnostic accuracy study of STANDARD TB-Feron FIA and STANDARD TB-Feron ELISA tests for tuberculosis infection diagnosis in Eastern European settingValeriu Crudu, Dumitru Chesov, Alexandru Codreanu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2023
Long-term treatment outcomes in patients with multidrug-resistant tuberculosisChristina Maier, Dumitru Chesov, Dagmar Schaub, et al.
Emerging Infectious Diseases|March 2, 2025
Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023Olha Konstantynovska, Tetiana Synenko, Alla Honcharenko, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 6, 2016
In replyMatthias Merker, Valeriu Crudu, Ecaterina Noroc, et al.
Respiration; International Review of Thoracic Diseases|May 31, 2021
Defining Outcomes of Tuberculosis (Treatment): From the Past to the FutureGunar Günther, Jan Heyckendorf, Jean Pierre Zellweger, et al.
The European Respiratory Journal|December 18, 2020
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden countryDumitru Chesov, Jan Heyckendorf, Sofia Alexandru, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 13, 2025
High rates of acquired resistance to fluoroquinolones, bedaquiline, and linezolid in patients failing treatment against drug-resistant tuberculosis in the Republic of MoldovaDumitru Chesov, Maja Reimann, Tishya Mukherjee, et al.
Pageof 4